Key takeawaysResearchers and scientists have engineered a new class of supercharged T cells that are stronger, longer-lasting ...
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, have engineered a new ...
Discover how fat cells, beyond mere storage, can be harnessed for innovative weight loss therapies through energy expenditure ...
Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer In experimental models, human CAR-T cells ...
Cbio A/S today announced that it has received regulatory clearance to begin a first-in-human Phase I/IIa clinical trial of novoleucel, the company’s next-generation T-cell therapy designed to improve ...
Copenhagen, Denmark Saturday, March 14, 2026, 14:00 Hrs [IST] ...
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
Learn how KMA and LMA represent a breakthrough in treatment approaches for multiple myeloma and related disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results